LGALS3 and Hepatic fibrosis: The above studies have shown that the Gal-3, secreted by macrophages, could contribute to hepatic fibrogenesis, this notion may suggest that Gal-3 could serve as a potential therapeutic target for the patients with liver fibrosis.